Resolution of early cytomegalovirus (CMV) infection after leukocyte transfusion therapy from a CMV seropositive donor

Bone Marrow Transplantation

Volumn 22, Issue 3, 1998, Pages 289-292

  Witt, V ^a   Fritsch, G ^a   Peters, C ^a   Matthes Martin, S ^a   Ladenstein, R ^a   Gadner, H ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

ABMT; CMV infection; Graft failure; Leukocyte transfusion; T cells

Indexed keywords

IMMUNOGLOBULIN G; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DONOR; GRAFT FAILURE; HUMAN; LEUKOCYTE; LEUKOCYTE TRANSFUSION; MALE; NEUROBLASTOMA; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SEPSIS; T LYMPHOCYTE;

EID: 0031829060     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701328     Document Type: Article

References (11)

1. Strauss RG. Therapeutic granulocyte transfusions. Blood, 1993; 81: 1675-1678.
2. Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
3. Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T cell-depleted bone marrow transplantation. Blood 1994; 84: 1689-1690.
4. Ridell SR, Watanabe KS, Goodrich JM et al. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science 1992; 257: 238-241.
5. Keil F, Hass OA, Fritsch G et al. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation; lack of residual donor hematopoiesis predicts aplasia. Blood 1997; 89: 3113-3117.
6. Krause H, Hebart H, Jahn G et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant 1997; 19: 1111-1116.
7. Fritsch G, Printz D, Stimpfl M et al. Quantitative CD34 analysis: comparison of methods. Transfusion 1997; 37: 775-784.
8. Strauss RG. Clinical perspectives of granulocyte transfusions: efficacy to date. J Clin Apher 1995; 10: 114-118.
9. Rosen NR, Weidner JG, Boldt HD, Rosen DS. Prevention of transfusion-associated graft-versus-host disease: selection of adequate dose of gamma radiation. Transfusion 1993; 33: 125-127.
10. Igietseme JU, Smith K, Simmons A, Rayford PL. Effect of gamma-irradiation on the effector function of T lymphocytes in microbial control. Int J Radiat Biol 1995; 67: 557-564.
11. Boise LH, Minn AJ, June CH et al. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci USA 1995; 92: 5491-5495.